Search results for Motavizumab
Motavizumab, Abbexa, abx831018
Motavizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Respiratory Syncytial Virus (RSV), for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Motavizumab is a second generation, ultra-potent, affinity-matured, humanized mAb derived from palivizumab that reduces replication of Respiratory Syncytial Virus (RSV), a pathogen which causes lower respiratory tract disease.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Motavizumab Biosimilar - Research Grade, ichor.bio, ICH5169
Detects human RSV
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Motavizumab (VK421036), abinScience, VK421036
Host
Humanized
Reactivity
HRSV-A
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.